Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: A novel agonist of PPAR-γ based on barbituric acid alleviates the development of non-alcoholic fatty liver disease by regulating adipocytokine expression and preventing insulin resistance, European Journal of Pharmacology, June 2011, Elsevier,
DOI: 10.1016/j.ejphar.2011.03.033.
You can read the full text:
Contributors
The following have contributed to this page
